More than 30 years of intensive research towards an active HIV-1 vaccine have not yielded immunogens derived from the viral envelope protein (Env) that are able to induce broadly neutralizing antibodies (bnAbs) as an important correlate of protection from viral infections to date. Here, ERVW-1 is linked to viral infectious disease.